173 related articles for article (PubMed ID: 19912064)
1. Multisubstrate adduct inhibitors: drug design and biological tools.
Le Calvez PB; Scott CJ; Migaud ME
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1291-318. PubMed ID: 19912064
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
3. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.
Copeland RA
Methods Biochem Anal; 2005; 46():1-265. PubMed ID: 16350889
[No Abstract] [Full Text] [Related]
5. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
Rigden DJ; Botzki A; Nukui M; Mewbourne RB; Lamani E; Braun S; von Angerer E; Bernhardt G; Dove S; Buschauer A; Jedrzejas MJ
Glycobiology; 2006 Aug; 16(8):757-65. PubMed ID: 16638841
[TBL] [Abstract][Full Text] [Related]
6. Molecular design of cholesterols as inhibitors of DNA polymerase alpha.
Oshige M; Kuramochi K; Ohta K; Ogawa A; Kuriyama H; Sugawara F; Kobayashi S; Sakaguchi K
J Med Chem; 2004 Sep; 47(20):4971-4. PubMed ID: 15369402
[TBL] [Abstract][Full Text] [Related]
7. Non-competitive inhibition by active site binders.
Blat Y
Chem Biol Drug Des; 2010 Jun; 75(6):535-40. PubMed ID: 20374252
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic basis of enzyme-targeted drugs.
Robertson JG
Biochemistry; 2005 Apr; 44(15):5561-71. PubMed ID: 15823014
[TBL] [Abstract][Full Text] [Related]
9. Cofactor chemogenomics.
Singh R; Mozzarelli A
Methods Mol Biol; 2009; 575():93-122. PubMed ID: 19727612
[TBL] [Abstract][Full Text] [Related]
10. The development of molecular clamps as drugs.
Weiss ST; McIntyre NR; McLaughlin ML; Merkler DJ
Drug Discov Today; 2006 Sep; 11(17-18):819-24. PubMed ID: 16935750
[TBL] [Abstract][Full Text] [Related]
11. Searching for new allosteric sites in enzymes.
Hardy JA; Wells JA
Curr Opin Struct Biol; 2004 Dec; 14(6):706-15. PubMed ID: 15582395
[TBL] [Abstract][Full Text] [Related]
12. A graphical method for determining inhibition constants.
Yoshino M; Murakami K
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1288-90. PubMed ID: 19912063
[TBL] [Abstract][Full Text] [Related]
13. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
14. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors.
Hu L; Chen G; Chau RM
J Mol Graph Model; 2006 Jan; 24(4):244-53. PubMed ID: 16226911
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
[TBL] [Abstract][Full Text] [Related]
16. Cell biology. Lessons in rational drug design for protein kinases.
Ahn NG; Resing KA
Science; 2005 May; 308(5726):1266-7. PubMed ID: 15919981
[No Abstract] [Full Text] [Related]
17. Enzyme inhibitors as chemical tools to study enzyme catalysis: rational design, synthesis, and applications.
Hiratake J
Chem Rec; 2005; 5(4):209-28. PubMed ID: 16041744
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic transition states: thermodynamics, dynamics and analogue design.
Schramm VL
Arch Biochem Biophys; 2005 Jan; 433(1):13-26. PubMed ID: 15581562
[TBL] [Abstract][Full Text] [Related]
19. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
Toms AV; Wang W; Li Y; Ganem B; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1449-58. PubMed ID: 16239721
[TBL] [Abstract][Full Text] [Related]
20. C3-Spacer-containing circular oligonucleotides as inhibitors of human topoisomerase I.
Wang Y; Ng MT; Zhou T; Li X; Tan CH; Li T
Bioorg Med Chem Lett; 2008 Jun; 18(12):3597-602. PubMed ID: 18490159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
